HealthTree Logo
search more_vert
close
person Sign In / Create Account
Killing AML Cells with Magrolimab, a New Immunotherapy Option, with Dr. Joseph Jurcic
Killing AML Cells with Magrolimab, a New Immunotherapy Option, with Dr. Joseph Jurcic  image
HealthTree Podcast for AML
event May 26, 2022 / 11:00AM EDT

Event Description

IF YOU WOULD PREFER TO JOIN THE SHOW BY PHONE, PLEASE CALL (515) 602-9728

*you need to join by phone if you want to ask Dr. Jurcic your questions.

Immunotherapy is one of the most promising areas of cancer research. Drugs like checkpoint inhibitors, monoclonal and bispecific anitbodies, antibody drug conjugates and CAR-T cell therapy are all extensively being studied in AML. 

Join us live on May 26th at 11 AM EST to learn from Dr. Joseph Jurcic, an AML expert from the Herbert Irving Comprehensive Cancer Center at Columbia University, about an exciting new immunotherapy drug in development called magrolimab which is a monoclonal antibody against CD47 and macrophage checkpoint inhibitor. 

During the show, Dr. Jurcic will discuss what magrolimab is, how it is helping AML patients and two upcoming trials he will be participating in that will use magrolimab in combination with other AML drugs. Learn all about the immune system and this emerging therapy with a unique opportunity to directly ask Dr. Jurcic your questions! 

Schedule & Agenda

person
Welcome
11:00AM
Kerith Amen
Welcome, announcements and introduction
person
Interview
11:05AM
Dr. Joseph Jurcic
Dr. Jurcic will discuss what magrolimab is, how it is helping AML patients and two upcoming trials he will be participating in that will use magrolimab in combination with other AML drugs.
person
Questions and Answers
11:50AM
Audience
Audience is able to call in to the radio show (515) 602-9728 to ask Dr. Jurcic questions about what was discussed during our interview today.

Speakers & Moderators

The panelist Joseph Jurcic, MD
Joseph Jurcic, MD
New York, NY

Attending Physician in the Deparment of Medicine at New York-Presbyterian/Columbia University Medical Center, Professor of Medicine at Columbia University Irving Medical Center and Director of the Hematologic Malignancies Section in the Division of Hematology/Oncology.

Read Bio
The panelist Kerith Amen
Kerith Amen
New Orleans, Louisiana

Kerith joined HealthTree Foundation as a Community Co-Director for AML in 2022. She is a mother to a spirited eight-year-old daughter, Adair, and their beloved rescue, Violet. She lost her best friend and husband, Rob, to AML in March 2018. Kerith wishes she had a resource such as HealthTree for AML during Rob’s illness. She is a strong supporter of HealthTree's mission. She hopes that by sharing her experience, she may help other patients and caregivers navigate an AML diagnosis.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life with Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Abbvie
Astellas Pharma
Servier

Follow Us

facebook twitter